APA (7th ed.) Citation

Louis, K., Tanith, W., Balwinder, K., Nikolaos, G., & Adam, J. (2025). 263 The use of 3,4-Diaminopyridine (3,4-DAP) in the management of life-threatening paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A case report. Lung Cancer (01695002), 200, N.PAG. https://doi.org/10.1016/j.lungcan.2025.108372

Chicago Style (17th ed.) Citation

Louis, Kennedy, Westerman Tanith, Kolotia Balwinder, Gorgoraptis Nikolaos, and Januszewski Adam. "263 The Use of 3,4-Diaminopyridine (3,4-DAP) in the Management of Life-threatening Paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A Case Report." Lung Cancer (01695002) 200 (2025): N.PAG. https://doi.org/10.1016/j.lungcan.2025.108372.

MLA (9th ed.) Citation

Louis, Kennedy, et al. "263 The Use of 3,4-Diaminopyridine (3,4-DAP) in the Management of Life-threatening Paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A Case Report." Lung Cancer (01695002), vol. 200, 2025, p. N.PAG, https://doi.org/10.1016/j.lungcan.2025.108372.